These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8499666)

  • 1. Otis workshop on risk assessment.
    Chernoff GF
    Reprod Toxicol; 1993; 7(2):163-9. PubMed ID: 8499666
    [No Abstract]   [Full Text] [Related]  

  • 2. Funding for teratology information services: up, down, and all around.
    Quinn D
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):660-3. PubMed ID: 22678653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do we have a knowledge transfer and translation plan at Teratogen Information Services?
    Einarson A; Lockett D
    Reprod Toxicol; 2006 Oct; 22(3):542-5. PubMed ID: 16564671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OTIS special issue preface.
    Chambers C; Friedman JM
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):569. PubMed ID: 22847972
    [No Abstract]   [Full Text] [Related]  

  • 5. Formation of the Organization of Teratology Information Services (OTIS). The OTIS Executive Committee.
    O'Brien J; Conover B; Frias J; Koren G; Quinn D; Robert E; Rosenwasser S
    Reprod Toxicol; 1991; 5(5):463. PubMed ID: 1806156
    [No Abstract]   [Full Text] [Related]  

  • 6. Human teratogens: update 2010.
    Holmes LB
    Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):1-7. PubMed ID: 21254353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The practical application of three validated in vitro embryotoxicity tests. The report and recommendations of an ECVAM/ZEBET workshop (ECVAM workshop 57).
    Spielmann H; Seiler A; Bremer S; Hareng L; Hartung T; Ahr H; Faustman E; Haas U; Moffat GJ; Nau H; Vanparys P; Piersma A; Sintes JR; Stuart J
    Altern Lab Anim; 2006 Oct; 34(5):527-38. PubMed ID: 17121476
    [No Abstract]   [Full Text] [Related]  

  • 8. Framework for provision of Teratology Information Services.
    Reprod Toxicol; 1994; 8(5):439-42. PubMed ID: 7841665
    [No Abstract]   [Full Text] [Related]  

  • 9. Identifying teratogens: the tyranny of lists.
    Scialli AR
    Reprod Toxicol; 1997; 11(4):555-9. PubMed ID: 9241676
    [No Abstract]   [Full Text] [Related]  

  • 10. The Florida Teratogen Information Service.
    LaFauce L; Williams CA; Ausbon W; Moffett M
    J Fla Med Assoc; 1988 Dec; 75(12):814-6. PubMed ID: 3209989
    [No Abstract]   [Full Text] [Related]  

  • 11. [Risk evaluation and information on drug-induced teratogenesis].
    Elefant E; Roux C
    Therapie; 1985; 40(5):297-300. PubMed ID: 4095685
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings of the Consensus Workshop on In Vitro Teratogenesis Testing. August 2-5, 1981 Arkadelphia, Arkansas.
    Teratog Carcinog Mutagen; 1982; 2(3-4):221-374. PubMed ID: 6130621
    [No Abstract]   [Full Text] [Related]  

  • 13. Who seeks Teratology Information Service's advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy.
    Beck E; Lechner A; Schaefer C
    Reprod Toxicol; 2017 Jan; 67():79-84. PubMed ID: 27915015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Organization of Teratology Information Services (OTIS) Registry Study.
    Scialli AR
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 2):S373-6. PubMed ID: 9949342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge transfer and translation: examining how teratogen information is disseminated.
    Shahin I; Einarson A
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):956-61. PubMed ID: 21948595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of maternal and developmental toxicity. Proceedings of the consensus workshop. Rockville, Maryland, May 12-14, 1986.
    Teratog Carcinog Mutagen; 1987; 7(3):201-338. PubMed ID: 2888200
    [No Abstract]   [Full Text] [Related]  

  • 17. Human teratogens and evidence-based teratogen risk counseling: the Motherisk approach.
    Nava-Ocampo AA; Koren G
    Clin Obstet Gynecol; 2007 Mar; 50(1):123-31. PubMed ID: 17304029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemicals which cause birth defects--teratogens: a special concern of research chemists.
    Meyers VK
    Sci Total Environ; 1983 Dec; 32(1):1-12. PubMed ID: 6665552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making information work.
    Scialli AR
    Reprod Toxicol; 1990; 4(4):249-50. PubMed ID: 2136044
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current prospects of experimental drug embryotoxicity risk assessment (author's transl)].
    Jelínek R; Rychter Z
    Cas Lek Cesk; 1981 Oct; 120(43):1309-12. PubMed ID: 7307040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.